Summary of experience in treating non-proliferative diabetic retinopathy with traditional Chinese medicine based on data mining and network pharmacology
WU Xiaocui1 YANG Zhihua2 XIE Yiqiang3 LI Rui4 CHENG Yawei5
1.Department of Endocrinology, Hainan Provincial Hospital of Chinese Medicine, Hainan Province, Haikou 570203, China;
2.Guangzhou University of Chinese Medicine, Guangdong Province, Guangzhou 510006, China;
3.School of Chinese Medicine, Hainan Medical College, Hainan Province, Haikou 571199, China;
4.Department of Ophthalmology, Hainan Provincial Hospital of Chinese Medicine, Hainan Province, Haikou 570203, China;
5.Department of Preventive Treatment of Disease, Hainan Provincial Hospital of Chinese Medicine, Hainan Province, Haikou 570203, China
Abstract:Objective To summarize the experience of traditional Chinese medicine in treating non-proliferative diabetic retinopathy (NPDR) based on data mining and network pharmacology. Methods Literatures of treating NPDR with traditional Chinese medicine from CNKI and Wanfang Data were searched and collated, and the limited time was from inception to December 2020. Traditional Chinese medicine inheritance computing platform V 3.0 was used to build a prescription database, and the frequency, flavor, meridian transformation, and efficacy of related prescriptions were counted. Association rules of related drug pairs were analyzed, and medication rules and core compatibility of traditional Chinese medicine treatment of NPDR were summarized. For the core drug pairs, the traditional Chinese medicine systems pharmacology database and analysis platform, traditional Chinese medicine integrative database, Uniprot, and GeneCards were used to construct the “ingredient-target” network, and the protein-protein interaction network was constructed with STRING database and Cytoscape software, and molecular docking was carried out. GO classification enrichment analysis and KEGG pathway enrichment analysis were performed by R language. Results According to the analysis of 107 prescriptions of NPDR treated by traditional Chinese medicine, ten drugs were commonly used, among which Radix Astragali seu Hedysari, Radix Rehmanniae Recens, and Radix Notoginseng were the most frequently used. The four nature of drugs were mainly cold, flat, and warm, the five flavours were mainly bitter and sweet, the channel tropism were mainly liver, lung, and kidney channel. There were seven drug pairs with high frequency of use, among which Radix Astragali seu Hedysari-Radix Rehmanniae Recens, Radix Astragali seu Hedysari-Radix Notoginseng, and Radix Astragali seu Hedysari- Radix Notoginseng ranked the top three. Network pharmacological analysis of the Radix Astragali seu Hedysari-Radix Rehmanniae Recens drug pair showed that the main components included quercetin, kaempferol, formononetin, isorhamnetin, etc., and the main targets included TP53, SERPINE1, VEGFA, TNF, etc. KEGG and GO enrichment pathways showed that the active components of traditional Chinese medicine were related to cell proliferation, cell response to chemical stress, and cell response to lipopolysaccharide. The free energy calculation of core target protein and core active ingredient showed that the core active ingredient in Radix Astragali seu Hedysari-Radix Rehmanniae Recens drug pair (quercetin, kaempferol) had a good binding effect with the key core target in NPDR. Conclusion Radix Astragali seu Hedysari-Radix Rehmanniae Recens is a high-frequency drug for NPDR treatment in traditional Chinese medicine. Its components may play a regulatory role on multiple pathways by acting on multiple targets, which can provide guidance for clinical and basic research.
吴小翠1 杨智华2 谢毅强3 李瑞4 程亚伟5. 基于数据挖掘与网络药理学技术的中药治疗非增殖期糖尿病视网膜病变经验总结[J]. 中国医药导报, 2022, 19(36): 21-28.
WU Xiaocui1 YANG Zhihua2 XIE Yiqiang3 LI Rui4 CHENG Yawei5. Summary of experience in treating non-proliferative diabetic retinopathy with traditional Chinese medicine based on data mining and network pharmacology. 中国医药导报, 2022, 19(36): 21-28.